In colon cancer cells, the activation of HER3 by its ligand heregulin strongly induces COX-2 expression and PGE2, thus leading to an increase in cell proliferation and motility via activation of the PI3K/Akt pathway [62, 63]. This evidence concerns the gene AKT1 and colonic neoplasm.